Search research articles
Contact Us
Filters
Showing results (131-140 of 289) with videos related to
Page
of 29
Sort By:
Journal of Oncology Practice
|
June 16, 2018
The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey
M Kelsey Kirkwood, Amy Hanley, Suanna S Bruinooge, et al.
JCO Global Oncology
|
September 19, 2025
Understanding Barriers to Clinical Cancer Research in the Asia-Pacific
Rashid N Lui, Jimmy Billod, Sophia Frentzas, et al.
Journal of Geriatric Oncology
|
February 24, 2021
Challenges and opportunities to developing a frailty index using electronic health record data
Laura A Levit, Melinda W Kaltenbaugh, Allison Magnuson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung
Jyoti Mehrotra, Mustafa Vali, Megan McVeigh, et al.
Urology
|
March 27, 2007
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy
Gopal K Bajaj, Zhe Zhang, Elizabeth Garrett-Mayer, et al.
American Journal of Clinical Oncology
|
October 21, 2009
Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer
Bree N Ruppert, John M Watkins, Keisuke Shirai, et al.
Japanese Journal of Radiology
|
June 30, 2010
Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes
John M Watkins, John A Fortney, Amy E Wahlquist, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2025
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy
Thomas U Marron, Jason J Luke, Brianna Hoffner, et al.
Journal of Medical Imaging and Radiation Oncology
|
October 21, 2010
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival
John M Watkins, Amy E Wahlquist, A Jason Zauls, et al.
Neoplasia (New York, N.Y.)
|
September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer
Colin D Weekes, Dongweon Song, John Arcaroli, et al.
Page
of 29
Search research articles
Search
Showing results (131-140 of 289) with videos related to
Sort By:
Page
of 29
Journal of Oncology Practice
|
June 16, 2018
The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey
M Kelsey Kirkwood, Amy Hanley, Suanna S Bruinooge, et al.
JCO Global Oncology
|
September 19, 2025
Understanding Barriers to Clinical Cancer Research in the Asia-Pacific
Rashid N Lui, Jimmy Billod, Sophia Frentzas, et al.
Journal of Geriatric Oncology
|
February 24, 2021
Challenges and opportunities to developing a frailty index using electronic health record data
Laura A Levit, Melinda W Kaltenbaugh, Allison Magnuson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung
Jyoti Mehrotra, Mustafa Vali, Megan McVeigh, et al.
Urology
|
March 27, 2007
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy
Gopal K Bajaj, Zhe Zhang, Elizabeth Garrett-Mayer, et al.
American Journal of Clinical Oncology
|
October 21, 2009
Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer
Bree N Ruppert, John M Watkins, Keisuke Shirai, et al.
Japanese Journal of Radiology
|
June 30, 2010
Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes
John M Watkins, John A Fortney, Amy E Wahlquist, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2025
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy
Thomas U Marron, Jason J Luke, Brianna Hoffner, et al.
Journal of Medical Imaging and Radiation Oncology
|
October 21, 2010
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival
John M Watkins, Amy E Wahlquist, A Jason Zauls, et al.
Neoplasia (New York, N.Y.)
|
September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer
Colin D Weekes, Dongweon Song, John Arcaroli, et al.
Page
of 29